SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-22-022789
Filing Date
2022-02-14
Accepted
2022-02-14 16:11:49
Documents
1
Group Members
PETER KOLCHINSKYRA CAPITAL HEALTHCARE FUND, L.P.RAJEEV SHAH

Document Format Files

Seq Description Document Type Size
1 X4 PHARMACEUTICALS, INC tm225316d9_sc13ga.htm SC 13G/A 90484
  Complete submission text file 0001104659-22-022789.txt   92304
Mailing Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116 617-778-2500
RA CAPITAL MANAGEMENT, L.P. (Filed by) CIK: 0001346824 (see all company filings)

IRS No.: 830406777 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Subject) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90199 | Film No.: 22631913
SIC: 2836 Biological Products, (No Diagnostic Substances)